• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

跨越障碍:增强血脑屏障分子传递的策略。

Hopping the Hurdle: Strategies to Enhance the Molecular Delivery to the Brain through the Blood-Brain Barrier.

机构信息

Dementia Research Group, Korea Brain Research Institute, Daegu 41062, Republic of Korea.

Department of Brain & Cognitive Sciences, Daegu Gyeongbuk Institute of Science and Technology (DGIST), Daegu 42988, Republic of Korea.

出版信息

Cells. 2024 May 7;13(10):789. doi: 10.3390/cells13100789.

DOI:10.3390/cells13100789
PMID:38786013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11119906/
Abstract

Modern medicine has allowed for many advances in neurological and neurodegenerative disease (ND). However, the number of patients suffering from brain diseases is ever increasing and the treatment of brain diseases remains an issue, as drug efficacy is dramatically reduced due to the existence of the unique vascular structure, namely the blood-brain barrier (BBB). Several approaches to enhance drug delivery to the brain have been investigated but many have proven to be unsuccessful due to limited transport or damage induced in the BBB. Alternative approaches to enhance molecular delivery to the brain have been revealed in recent studies through the existence of molecular delivery pathways that regulate the passage of peripheral molecules. In this review, we present recent advancements of the basic research for these delivery pathways as well as examples of promising ventures to overcome the molecular hurdles that will enhance therapeutic interventions in the brain and potentially save the lives of millions of patients.

摘要

现代医学在神经学和神经退行性疾病(ND)方面取得了许多进展。然而,患有脑部疾病的患者人数不断增加,脑部疾病的治疗仍然是一个问题,因为由于独特的血管结构(即血脑屏障(BBB))的存在,药物的疗效大大降低。已经研究了几种增强药物向大脑输送的方法,但由于 BBB 中的有限转运或诱导的损伤,许多方法都被证明是不成功的。最近的研究揭示了通过存在调节外周分子通过的分子传递途径来增强分子向大脑传递的替代方法。在这篇综述中,我们介绍了这些传递途径的基础研究的最新进展,以及克服分子障碍的有前途的尝试的例子,这些障碍将增强大脑中的治疗干预措施,并有可能挽救数百万患者的生命。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/11119906/a09080d1ec68/cells-13-00789-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/11119906/a56f0f08e02c/cells-13-00789-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/11119906/4c1ccd78a665/cells-13-00789-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/11119906/e611133da906/cells-13-00789-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/11119906/8df66f660c5d/cells-13-00789-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/11119906/2f70742b6cd7/cells-13-00789-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/11119906/a09080d1ec68/cells-13-00789-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/11119906/a56f0f08e02c/cells-13-00789-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/11119906/4c1ccd78a665/cells-13-00789-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/11119906/e611133da906/cells-13-00789-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/11119906/8df66f660c5d/cells-13-00789-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/11119906/2f70742b6cd7/cells-13-00789-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/11119906/a09080d1ec68/cells-13-00789-g006.jpg

相似文献

1
Hopping the Hurdle: Strategies to Enhance the Molecular Delivery to the Brain through the Blood-Brain Barrier.跨越障碍:增强血脑屏障分子传递的策略。
Cells. 2024 May 7;13(10):789. doi: 10.3390/cells13100789.
2
Transforming brain cancer therapeutics: unlocking the power of blood-brain barrier-targeting strategies for superior treatment outcomes and precision medicine.脑癌治疗的变革:为卓越的治疗效果和精准医学解锁血脑屏障靶向策略的力量。
Neurosurg Rev. 2024 Sep 24;47(1):673. doi: 10.1007/s10143-024-02873-4.
3
Getting into the brain: approaches to enhance brain drug delivery.进入大脑:增强脑内药物递送的方法。
CNS Drugs. 2009;23(1):35-58. doi: 10.2165/0023210-200923010-00003.
4
Development of Novel Therapeutics Targeting the Blood-Brain Barrier: From Barrier to Carrier.新型血脑屏障靶向治疗药物的研发:从障碍到载体。
Adv Sci (Weinh). 2021 Aug;8(16):e2101090. doi: 10.1002/advs.202101090. Epub 2021 Jun 3.
5
Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain.穿越血脑屏障:脑内药物递送的最新进展
CNS Drugs. 2017 Feb;31(2):109-133. doi: 10.1007/s40263-016-0405-9.
6
Modern methods for delivery of drugs across the blood-brain barrier.现代跨越血脑屏障递药方法。
Adv Drug Deliv Rev. 2012 May 15;64(7):640-65. doi: 10.1016/j.addr.2011.11.010. Epub 2011 Nov 28.
7
Considerations When Developing Blood-Brain Barrier Crossing Drug Delivery Technology.开发血脑屏障穿透药物递送技术时需考虑的因素。
Handb Exp Pharmacol. 2022;273:83-95. doi: 10.1007/164_2021_453.
8
Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.纳米载体的进步使药物能够穿透血脑屏障靶向递送到大脑。
Int J Pharm. 2019 Mar 25;559:360-372. doi: 10.1016/j.ijpharm.2019.01.056. Epub 2019 Feb 2.
9
Strategies to improve drug delivery across the blood-brain barrier.改善药物透过血脑屏障递送的策略。
Clin Pharmacokinet. 2007;46(7):553-76. doi: 10.2165/00003088-200746070-00002.
10
Experimental methods and transport models for drug delivery across the blood-brain barrier.用于药物跨越血脑屏障传递的实验方法和输送模型。
Curr Pharm Biotechnol. 2012 Jun;13(7):1346-59. doi: 10.2174/138920112800624409.

引用本文的文献

1
Overcoming the blood-brain barrier (BBB) in pediatric CNS tumors: immunotherapy and nanomedicine-driven strategies.克服小儿中枢神经系统肿瘤中的血脑屏障:免疫疗法和纳米医学驱动策略
Med Oncol. 2025 Aug 19;42(10):431. doi: 10.1007/s12032-025-02984-y.
2
Layered double hydroxides for regenerative nanomedicine and tissue engineering: recent advances and future perspectives.用于再生纳米医学和组织工程的层状双氢氧化物:最新进展与未来展望。
J Nanobiotechnology. 2025 May 22;23(1):370. doi: 10.1186/s12951-025-03448-1.
3
Cerebral Aneurysm: Filling the Gap Between Pathophysiology and Nanocarriers.

本文引用的文献

1
Drug delivery to the central nervous system.药物向中枢神经系统的递送。
Nat Rev Mater. 2022 Apr;7(4):314-331. doi: 10.1038/s41578-021-00394-w. Epub 2021 Dec 3.
2
Macrophage Membrane-Modified MoS Quantum Dots as a Nanodrug for Combined Multi-Targeting of Alzheimer's Disease.巨噬细胞膜修饰的二硫化钼量子点作为一种用于阿尔茨海默病联合多靶点治疗的纳米药物
Adv Healthc Mater. 2024 Mar;13(6):e2303211. doi: 10.1002/adhm.202303211. Epub 2023 Nov 20.
3
Endocytosis of insulin at the blood-brain barrier.胰岛素在血脑屏障处的内吞作用。
颅内动脉瘤:填补病理生理学与纳米载体之间的空白。
Int J Mol Sci. 2024 Nov 5;25(22):11874. doi: 10.3390/ijms252211874.
4
All Blood Brain Barrier Cell Types Demonstrate Capability to Influence Differential Tenofovir and Emtricitabine Metabolism and Transport in the Brain.所有血脑屏障细胞类型均显示出影响替诺福韦和恩曲他滨在脑内代谢及转运差异的能力。
ACS Pharmacol Transl Sci. 2024 Oct 18;7(11):3626-3640. doi: 10.1021/acsptsci.4c00510. eCollection 2024 Nov 8.
5
Nanocarrier-mediated siRNA delivery: a new approach for the treatment of traumatic brain injury-related Alzheimer's disease.纳米载体介导的小干扰RNA递送:一种治疗创伤性脑损伤相关阿尔茨海默病的新方法。
Neural Regen Res. 2025 Sep 1;20(9):2538-2555. doi: 10.4103/NRR.NRR-D-24-00303. Epub 2024 Sep 24.
6
Drug Metabolism and Transport Capacity of Endothelial Cells, Pericytes, and Astrocytes: Implications for CNS Drug Disposition.内皮细胞、周细胞和星形胶质细胞的药物代谢与转运能力:对中枢神经系统药物处置的影响
bioRxiv. 2024 Aug 5:2024.08.01.606165. doi: 10.1101/2024.08.01.606165.
7
Polyamidoamine Dendrimers: Brain-Targeted Drug Delivery Systems in Glioma Therapy.聚酰胺胺树枝状大分子:胶质瘤治疗中的脑靶向给药系统
Polymers (Basel). 2024 Jul 15;16(14):2022. doi: 10.3390/polym16142022.
Front Drug Deliv. 2022;2. doi: 10.3389/fddev.2022.1062366. Epub 2022 Nov 24.
4
Translational strategies and systems biology insights for blood-brain barrier opening and delivery in brain tumors and Alzheimer's disease.用于血脑屏障开放和脑肿瘤及阿尔茨海默病递药的转化策略和系统生物学见解。
Biomed Pharmacother. 2023 Nov;167:115450. doi: 10.1016/j.biopha.2023.115450. Epub 2023 Sep 11.
5
Roles of Oxidative Stress and Nrf2 Signaling in Pathogenic and Non-Pathogenic Cells: A Possible General Mechanism of Resistance to Therapy.氧化应激和Nrf2信号通路在致病细胞和非致病细胞中的作用:一种可能的治疗抗性通用机制
Antioxidants (Basel). 2023 Jun 30;12(7):1371. doi: 10.3390/antiox12071371.
6
Macrophage membrane-encapsulated nitrogen-doped carbon quantum dot nanosystem for targeted treatment of Alzheimer's disease: Regulating metal ion homeostasis and photothermal removal of β-amyloid.巨噬细胞膜包裹氮掺杂碳量子点纳米系统用于阿尔茨海默病的靶向治疗:调节金属离子稳态和光热去除β-淀粉样蛋白。
J Colloid Interface Sci. 2023 Nov 15;650(Pt B):1749-1761. doi: 10.1016/j.jcis.2023.07.132. Epub 2023 Jul 22.
7
Advancing glioblastoma imaging: Exploring the potential of organic fluorophore-based red emissive carbon dots.推进胶质母细胞瘤成像:探索基于有机荧光团的红色发射碳点的潜力。
J Colloid Interface Sci. 2023 Nov 15;650(Pt B):1619-1637. doi: 10.1016/j.jcis.2023.07.107. Epub 2023 Jul 21.
8
Microfluidic Synthesis of Ultrasmall Chitosan/Graphene Quantum Dots Particles for Intranasal Delivery in Alzheimer's Disease Treatment.用于阿尔茨海默病治疗的鼻内给药的超小壳聚糖/石墨烯量子点颗粒的微流体制备
Small. 2023 Oct;19(40):e2207626. doi: 10.1002/smll.202207626. Epub 2023 Jun 12.
9
Role of Micelle Size in Cell Transcytosis-Based Tumor Extravasation, Infiltration, and Treatment Efficacy.胶束大小在基于细胞转胞吞的肿瘤外渗、浸润和治疗效果中的作用。
Nano Lett. 2023 May 10;23(9):3904-3912. doi: 10.1021/acs.nanolett.3c00449. Epub 2023 Apr 12.
10
BBB-on-a-chip with integrated micro-TEER for permeability evaluation of multi-functionalized gold nanorods against Alzheimer's disease.载有多功能金纳米棒的芯片上 BBB 模型用于评估阿尔茨海默病的通透性
J Nanobiotechnology. 2023 Mar 29;21(1):115. doi: 10.1186/s12951-023-01798-2.